Risedronate is the generic name for an osteoporosis medicine with brand names Actonel® and Atelvia®, products of Warner Chilcott. No generic versions of Actonel or Atelvia are available since the patents are still in effect. Actonel is slated to go off patent in 2013; however, other circumstances, such as lawsuits, could delay this. Refer to Actonel for complete information.
Expert Insights on Osteoporosis